May 22nd, 2013
Proceeds Will Continue to Advance Clinical Development of Innovative Therapies to Combat Multi-Drug Resistant Bacterial Infections
Seattle, May 22, 2013 - Cardeas Pharma Corporation, a biopharmaceutical company focused on the development of innovative therapies for the treatment of multi-drug resistant (MDR) bacterial infections, announced today the completion of a $34 million Series B round of financing. The round was led by new investor H.I.G. BioVentures, LLC, and also included existing investors Novo A/S, Avalon Ventures, Devon Park Bioventures and WRF Capital (Washington Research Foundation), as well as additional new investor Delphi Ventures. Aaron Davidson, Managing Director of H.I.G. BioVentures, will join the Cardeas Board of Directors.
May 16th, 2013
CONCORD — The New Hampshire Executive Council Wednesday approved the sale of the former campus of Great Bay Community College to Juliet Marine Systems, Inc. for a purchase price of $2.75 million.
May 15th, 2013
Hot database-as-a-service startup Cloudant has raised $12 million in its second round of funding, the company announced today.
Boston-based Cloudant was initially founded in Cambridge, Mas. in 2008 by three MIT physicists. The team struggled to move around multi-petabyte data sets and analyze those data sets wherever they went. So they ended up creating what would become Cloudant. (more…)
May 15th, 2013
Database-as-a-service (DBaaS) provider Cloudant has received $12m (£7.8m) to help it set up new offices, employ more staff and bring its technology to new markets.
The Boston-based company announced on Tuesday that existing investors Avalon Ventures, In-Q-Tel and Samsung Venture Investment Corporation, had upped their shares in the company, while new investors Rackspace, Devonshire Investors, and Toba Capital also also added money to the pot. (more…)
May 6th, 2013
Deanna Brown, who was the CEO of Federated Media, has joined e-singles startup Byliner as president, the company announced Thursday.